메뉴 건너뛰기




Volumn 163, Issue 2, 2010, Pages 424-426

Botulinum toxin type A for neuropathic itch

Author keywords

botulinum toxin type A; itching; neuropatic pruritus; notalgia paraesthetica

Indexed keywords

BOTULINUM TOXIN A;

EID: 77954880709     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09783.x     Document Type: Letter
Times cited : (32)

References (11)
  • 1
    • 70349513464 scopus 로고    scopus 로고
    • Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin
    • Gazerani P, Pedersen NS, Drewes AM, Arendt-Nielsen L. Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. Br J Dermatol 2009 161 : 737 745.
    • (2009) Br J Dermatol , vol.161 , pp. 737-745
    • Gazerani, P.1    Pedersen, N.S.2    Drewes, A.M.3    Arendt-Nielsen, L.4
  • 2
    • 29144502961 scopus 로고    scopus 로고
    • Neuroanatomy and neurophysiology of itch
    • Wallengren J. Neuroanatomy and neurophysiology of itch. Dermatol Ther 2005 18 : 292 303.
    • (2005) Dermatol Ther , vol.18 , pp. 292-303
    • Wallengren, J.1
  • 3
    • 33846968808 scopus 로고    scopus 로고
    • Placebo theory and its implications for research and clinical practice: A review of the recent literature
    • Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract 2007 7 : 4 20.
    • (2007) Pain Pract , vol.7 , pp. 4-20
    • Koshi, E.B.1    Short, C.A.2
  • 4
    • 34548079060 scopus 로고    scopus 로고
    • Successful treatment of notalgia paresthetica with botulinum toxin type A
    • Weinfeld PK. Successful treatment of notalgia paresthetica with botulinum toxin type A. Arch Dermatol 2007 143 : 980 982.
    • (2007) Arch Dermatol , vol.143 , pp. 980-982
    • Weinfeld, P.K.1
  • 5
    • 0036553463 scopus 로고    scopus 로고
    • Botulinum toxin type A injection in the treatment of lichen simplex: An open pilot study
    • Heckmann M, Heyer G, Brunner B, Plewig G. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol 2002 46 : 617 619.
    • (2002) J Am Acad Dermatol , vol.46 , pp. 617-619
    • Heckmann, M.1    Heyer, G.2    Brunner, B.3    Plewig, G.4
  • 6
    • 63049130988 scopus 로고    scopus 로고
    • Severe post-herpetic neuralgia successfully treated with botulinum toxin A: Three case reports
    • Sotiriou E, Apalla Z, Panagiotidou D, Ioannidis D. Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports. Acta Derm Venereol (Stockh) 2009 89 : 214 215.
    • (2009) Acta Derm Venereol (Stockh) , vol.89 , pp. 214-215
    • Sotiriou, E.1    Apalla, Z.2    Panagiotidou, D.3    Ioannidis, D.4
  • 7
    • 67549127798 scopus 로고    scopus 로고
    • Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial
    • Yuan RY, Sheu JJ, Yu JM et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009 72 : 1473 1478.
    • (2009) Neurology , vol.72 , pp. 1473-1478
    • Yuan, R.Y.1    Sheu, J.J.2    Yu, J.M.3
  • 8
    • 0037322405 scopus 로고    scopus 로고
    • Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin
    • Krämer HH, Angerer C, Erbguth F et al. Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J Neurol 2003 250 : 188 193.
    • (2003) J Neurol , vol.250 , pp. 188-193
    • Krämer, H.H.1    Angerer, C.2    Erbguth, F.3
  • 9
    • 34249742661 scopus 로고    scopus 로고
    • Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin
    • Tugnoli V, Capone JG, Eleopra R et al. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. Pain 2007 130 : 76 83.
    • (2007) Pain , vol.130 , pp. 76-83
    • Tugnoli, V.1    Capone, J.G.2    Eleopra, R.3
  • 10
    • 58149157911 scopus 로고    scopus 로고
    • Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
    • Gazerani P, Pedersen NS, Staahl C et al. Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain 2009 141 : 60 9.
    • (2009) Pain , vol.141 , pp. 60-9
    • Gazerani, P.1    Pedersen, N.S.2    Staahl, C.3
  • 11
    • 0034792766 scopus 로고    scopus 로고
    • Cutaneous field stimulation (CFS) in treatment of severe localized itch
    • Wallengren J, Sundler F. Cutaneous field stimulation (CFS) in treatment of severe localized itch. Arch Dermatol 2001 137 : 1323 1325.
    • (2001) Arch Dermatol , vol.137 , pp. 1323-1325
    • Wallengren, J.1    Sundler, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.